Calcium, Phosphorus, Parathyroid Hormone, and Cardiovascular Disease in Hemodialysis Patients: The USRDS Waves 1, 3, and 4 Study
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Animal studies suggest that calcium-phosphorus homeostatic abnormalities cause cardiovascular disease in uremia; few observational studies in humans have explored this. Associations in the retrospective United States Renal Data System Waves 1, 3, and 4 Study of 14,829 patients who were on hemodialysis on December 31, 1993, were examined. Mean age and duration of renal replacement therapy were 60.0 and 3.2 yr, respectively; 40.7% had diabetes. Quintiles (Q1 to Q5) of (albumin-adjusted) calcium were ≤8.7, 8.8 to 9.2, 9.3 to 9.6, 9.7 to 10.2, and >10.2 mg/dl; phosphorus, ≤4.4, 4.5 to 5.3, 5.4 to 6.3, 6.4 to 7.5, and >7.5 mg/dl; calcium-phosphorus product, ≤40.9, 41.0 to 50.1, 50.2 to 59.2, 59.3 to 71.0, and >71.0 mg2/dl2; and parathyroid hormone (PTH), ≤37, 38 to 99, 100 to 210, 211 to 480, and >480 pg/ml. Higher calcium levels were associated with fatal or nonfatal cardiovascular events (adjusted hazards ratio, 1.08 for Q5, versus Q1) and all-cause mortality (Q2, 1.07; Q4, 1.11; Q5, 1.14). Phosphorus levels were associated with cardiovascular events (Q2, 1.06; Q3, 1.13; Q4, 1.14; Q5, 1.25) and mortality (Q4, 1.10; Q5, 1.19), calcium-phosphorus product was associated with cardiovascular events (Q3, 1.09; Q4, 1.14; Q5, 1.24) and mortality (Q4, 1.09; Q5, 1.19), and PTH levels were associated with cardiovascular events (Q5, 1.12) and mortality (Q5, 1.17). Despite limitations (including retrospective design; noncurrent study era; and lack of serial calcium, phosphorus, and PTH measurements), this study suggests that disorders of calcium homeostasis are associated with fatal and nonfatal cardiovascular events and all-cause mortality in hemodialysis patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., & Chertow, G. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133041.27682.a2 · Cited by 2,687
Goodman, W. G., Goldin, J., Kuizon, B. D., Yoon, C., Gales, B., Sider, D., Wang, Y., Chung, J., Emerick, A., Greaser, L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422003 · Cited by 2,509
Block, G., Hulbert-Shearon, T., Levin, N., & Port, F. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9531176 · Cited by 2,354
Oodman, W. I. G. G., Oldin, J. O. G., Uizon, D. K., Oon, C. H. Y., Ales, B. A. G., Ider, D. O. S., Ang, W. C., Oanie, J., Hung, C., Merick, A. L. E., et al. (2000) · Cited by 2,191
London, G. M. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg414 · Cited by 1,859
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
Chertow, G. M., Burke, S. K., Raggi, P., & for the Treat to Goal Working Group (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00434.x · Cited by 1,462
GANESH, S. K., STACK, A. G., LEVIN, N. W., HULBERT-SHEARON, T., & PORT, F. K. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102131 · Cited by 1,204
Jollis, J. G., Ancukiewicz, M., DeLong, E. R., Pryor, D. B., Muhlbaier, L. H., & Mark, D. B. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-8-199310150-00011 · Cited by 625
Heart failure prevalence, incidence, and mortality in the elderly with diabetes
Bertoni, A. G., Hundley, W. G., Massing, M. W., Bonds, D. E., Burke, G. L., & Goff, D. C. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.699 · Cited by 596
Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins
Moe, S. M., O'Neill, K. D., Duan, D., Ahmed, S., Chen, N. X., Leapman, S. B., Fineberg, N., & Kopecky, K. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00170.x · Cited by 448
Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure
Rostand, S. G., & Drüeke, T. B. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00575.x · Cited by 419
Bushinsky, D. A., & Monk, R. D. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12331-5 · Cited by 389
Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells
Chen, N. X., O'Neill, K. D., Duan, D., & Moe, S. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00625.x · Cited by 335
A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia.
Amann, K., Ritz, E., Wiest, G., Klaus, G., & Mall, G. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v4101814 · Cited by 255
Locatelli, F. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.5.723 · Cited by 203
Tamashiro, M., Iseki, K., Sunagawa, O., Inoue, T., Higa, S., Afuso, H., & Fukiyama, K. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.25195 · Cited by 152
Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients
London, G. M., de Vernejoul, M. C., Fabiani, F., Marchais, S. J., Guérin, A. P., Métivier, F., London, A. M., & Llach, F. (1987) · Kidney International · doi:10.1038/ki.1987.293 · Cited by 123
Kosch, M. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00130-9 · Cited by 116
Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes
Smogorzewski, M. J., Zayed, M., Zhang, Y. B., Roe, J., & Massry, S. G. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.264.6.h1998 · Cited by 106
Cardiac Disease in Chronic Uremia: Pathophysiology
Amann, K., & Ritz, E. (1997) · Advances in Renal Replacement Therapy · doi:10.1016/s1073-4449(97)70030-x · Cited by 105
Amann, K., Törnig, J., Flechtenmacher, C., Nabokov, A., Mall, G., & Ritz, E. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.11.2043 · Cited by 105
Cause of death in patients with end-stage renal disease: death certificates vs registry reports.
Perneger, T., Klag, M. J., & Whelton, P. K. (1993) · American Journal of Public Health · doi:10.2105/ajph.83.12.1735 · Cited by 69
Beyond Framingham: Cardiovascular Risk Profiling in ESRD
McClellan, W. M., & Chertow, G. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040415 · Cited by 29
Cited by
Kalantar-Zadeh, K., Kuwae, N., Regidor, D. L., Kovesdy, C. P., Kilpatrick, R. D., Shinaberger, C. S., McAllister, C. J., Budoff, M. J., Salusky, I. B., & Kopple, J. D. (2006) · Kidney International · doi:10.1038/sj.ki.5001514 · Cited by 905
Hyperphosphatemia of chronic kidney disease
Hruska, K. A., Mathew, S., Lund, R., Qiu, P., & Pratt, R. (2008) · Kidney International · doi:10.1038/ki.2008.130 · Cited by 438
Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder
Fukagawa, M., Yokoyama, K., Koiwa, F., Taniguchi, M., Shoji, T., Kazama, J. J., Komaba, H., Ando, R., Kakuta, T., Fujii, H., et al. (2013) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12058 · Cited by 402
Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
Mirza, M. A. I., Larsson, A., Lind, L., & Larsson, T. E. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.01.001 · Cited by 386
Metadata
- Authors
- Slinin, Y., Foley, R. N., & Collins, A. J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-06
- Volume
- 16
- Issue
- 6
- Pages
- 1788-1793
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2164919062
- Cited by
- 423
- References
- 23
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.